Exenatide Completed Phase 4 Trials for Polycystic Ovarian Syndrome (PCOS) / Overweight and Obesity / Disorder of Glucose Regulation Treatment

Back to Exenatide

Indications	Status	Purpose	Phase
DBCOND0062250 (Polycystic Ovarian Syndrome (PCOS)) DBCOND0038732 (Overweight and Obesity) DBCOND0049720 (Disorder of Glucose Regulation)	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT03352869	Research of Exenatide for Overweight/Obese PCOS Patients With IGR	Exenatide (DB01276) Metformin (DB00331)